Remove 2016 Remove Doctors Remove Physicians
article thumbnail

Telehealth will be worth about $25 billion in 2021

World of DTC Marketing

SUMMARY: Deloitte predicts that the percentage of virtual video visits to doctors will rise to 5% globally in 2021, up from an estimated 1% in 2019. billion doctor’s visits, worth a total of approximately US$500 billion. The most time-consuming task is to make an appointment with your doctor just to ask for a new Rx or an Rx renewal.

Doctors 309
article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

Worldwide obesity rates have tripled since 1975, with 650 million adults obese in 2016, according to the World Health Organization. But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it. In addition, doctors may not be ready to prescribe the drug.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Health consumers: A long way off

World of DTC Marketing

Consumers are seeking and embracing health outside of the traditional bricks-and-mortar sites of hospitals, doctors’ offices, and diagnostic centers. In 2016, consumers told Aflac that enrolling in health insurance should feel like an experience on Amazon. They want to know exactly what they’re getting for their money.

article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars.

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 Doctors can also cut down on the guesswork involved in finding treatments, enabling them to see more patients. billion in the United States alone.

article thumbnail

The Bus, The Car and The Bike: Explaining Intersectionality

InCrowd

I often use myself as an example; I am a Latina, immigrant, young physician, all identities for which I need to pay a price and fight the biases associated with each. In addition, as a physician under 40 years old, I often encounter scenarios in which I am told, “you are too young to know,” we will call this the age tax.